Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)
China · Delayed Price · Currency is CNY 10.42
-0.41 (-3.79%)
At close: Nov 21, 2025
SHE:301301 Market Cap
SHE:301301 has a market cap or net worth of 23.24 billion as of November 21, 2025. Its market cap has decreased by -26.32% in one year.
Market Cap
23.24B
Enterprise Value
23.74B
Revenue
4.74B
Ranking
n/a
PE Ratio
24.94
Stock Price
10.42
Market Cap Chart
Since December 27, 2022, SHE:301301's market cap has increased from 22.34B to 23.24B, an increase of 4.02%. That is a compound annual growth rate of 1.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 23.24B | -12.03% |
| Dec 31, 2024 | 26.41B | 41.47% |
| Dec 29, 2023 | 18.67B | -6.15% |
| Dec 30, 2022 | 19.89B | -10.95% |
| Dec 27, 2022 | 22.34B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 394.36B |
| WuXi AppTec | 272.52B |
| Shenzhen Mindray Bio-Medical Electronics | 235.96B |
| Sichuan Biokin Pharmaceutical | 154.69B |
| Shanghai United Imaging Healthcare | 109.47B |
| Aier Eye Hospital Group | 108.67B |
| Zhangzhou Pientzehuang Pharmaceutical., | 106.30B |
| Yunnan Baiyao Group Co.,Ltd | 99.31B |